DTL
ARGS

Dynamic Technology Lab’s Argos Therapeutics, Inc. ARGS Stock Holding History

Dynamic Technology Lab’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-950
Closed -$94K – 1399
2016
Q3 		$94K Buy
+950
New +$99.2K 0.03% 818

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dynamic Technology Lab's ARGS Position: Q4 2016 in Review

Dynamic Technology Lab sold out of Argos Therapeutics, Inc. (ARGS) in Q4 2016, closing a stake of 950 shares — an estimated $94K sold.

Dynamic Technology Lab first reported a position in ARGS in Q3 2016 and held it in 1 quarter. The position peaked at $94K in Q3 2016. 52 funds tracked by Wall St. Rank hold ARGS as of Q4 2016.

  • Dynamic Technology Lab reported no remaining Argos Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Dynamic Technology Lab sold 950 Argos Therapeutics, Inc. shares in Q4 2016, an estimated $94K.
  • Dynamic Technology Lab first reported a position in Argos Therapeutics, Inc. in Q3 2016 and held it in 1 quarter.
  • Dynamic Technology Lab's Argos Therapeutics, Inc. position peaked at $94K in Q3 2016.
  • 52 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2016.

Based on Dynamic Technology Lab's 13F filing for Q4 2016, filed 13 Feb 2017.